HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Coronavirus Situation 'Evolving Very Rapidly' Says AESGP

Executive Summary

In response to the outbreak of the Covid-19 pandemic in Europe, the region's self-care industry is working hard to keep shelves stocked with crucial OTC medicines, food supplements and self-care medical devices, according to the AESGP.

You may also be interested in...



Coronavirus-Related Free Trade Blocks Placing Strain On EU Food Supplements Supply Chain

Exclusive: How are import/export restrictions both within and outside the European Union affecting the food supplements industry supply chain? HBW Insight speaks to Food Supplements Europe and the International Alliance of Dietary/Food Supplements Associations to find out. 

Supplement Industry Summit Postponed, But Sales Jump As Consumers Respond To Covid-19

Dietary Supplements Regulatory Summit scheduled for 27 May in Washington is postponed. Even as supplies from China are slowed or interrupted due to Covid-19, though, sales of some consumer health products jump as consumers respond to the public health threat.

Covid-19 Disrupting Supply Chains Short-Term, Could Spark Long-Term Procurement Shifts

UNPA anticipates supplies of a ‘significant number’ of China-sourced supplement ingredients will be ‘critical’ by late April as Covid-19 disrupts shipments. During a recent webinar, UNPA CEO Loren Israelsen said he expects disruptions to continue until at least mid-year.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149802

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel